InvestorsHub Logo
Followers 2
Posts 253
Boards Moderated 0
Alias Born 06/04/2007

Re: None

Thursday, 03/04/2010 10:44:21 PM

Thursday, March 04, 2010 10:44:21 PM

Post# of 1874
RBC Capital Markets' Healthcare Conference Panel

The Palace Hotel New York, March 3rd panel titled Cancer: Improving Treatment Through Combination Therapy

Brad Thompson CEO of Oncolytics was invited to be on this panel discussion which was webcast. You can listen to the 4 Person moderated panel discussion at the following Wall Street Webcast link.

http://www.wsw.com/webcast/rbc116/panel15/

Listen to Brad and the other panelists talk about current clinical trials including news from Brad of a planned 3 arm trial for Pancreatic cancer with Reolysin+Carbotax, hear about the challenges in the development of Reolysin and other compounds that are new agents, thoughts on partnering --- Lots of good stuff here! and what is expected in the next 12-18 months --- for ONCY Phase IIIa (80 patient) data from H&N, a potential partnership and then in the next 3-5 year range a partnership and/or potential sale of the company.

Quite a long discussion but very informative and diverse points of view from 4 different companies.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ONCY News